Page last updated: 2024-08-23

haloperidol decanoate and Chronic Disease

haloperidol decanoate has been researched along with Chronic Disease in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (52.38)	18.7374
1990's	9 (42.86)	18.2507
2000's	1 (4.76)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Roncoroni, D	1
Youssef, HA	2
Aerts, TJ; Gelders, YG; Heykants, JJ; Reyntigens, AJ; Woestenborghs, RJ	1
Aerts, TJ; Ash, CW; Gelders, YG; Reyntijens, AJ	1
Maj, M; Martino, M; Monteleone, P; Piccolo, A	1
Anderson, C; Ereshefsky, L; Saklad, SR; Seidel, D; Toney, G	1
Chang, WH; Chen, LC; Jann, MW; Juang, DJ; Lane, HY; Lin, SK; Yang, CH	1
Chang, WH; Jann, MW; Lin, HN; Piao-Chien, C; Wei, FC	1
Dhopesh, V; Gamble, G; Maany, I; Macfadden, A	1
Conley, RR; Kelly, DL; Love, RC; Moore, DB; Sherr, JD	1
Averill, P; Hays, JR; Varner, RV; Wagner, AL	1
Koskinen, T; Mølbjerg, C; Nerdrum, T; Pedersen, V; Thelander, S; Wistedt, B	1
Eklund, K; Forsman, A	1
Brizuela, A; Caruso, S; Cuervo, L; Marchant, N	1
Kissling, W; Möller, HJ	1
McCreadie, RG; McKane, JP; Robinson, AD; Stirling, GS; Wiles, DH	1
Achim, A; Lizondo, E; Nayak, R; Schwartz, G; Suranyi-Cadotte, B; Thavundayil, JX; Vasavan Nair, NP	1
Wistedt, B	1
Leff, JP; Tress, KH	1
Agnoli, A; Casacchia, M; Falaschi, P; Meco, G; Petrini, P; Rocco, A; Rosa, M	1

Trials

7 trial(s) available for haloperidol decanoate and Chronic Disease

Article	Year
[Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics]. Acta psiquiatrica y psicologica de America latina, 1984, Volume: 30, Issue:4 Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia, Paranoid	1984
A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:7 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Patient Compliance; Prospective Studies; Recurrence; Schizophrenia; Treatment Outcome	1996
Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study. Acta psychiatrica Scandinavica, 1991, Volume: 84, Issue:1 Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Double-Blind Method; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Factors	1991
Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo. Clinical neuropharmacology, 1991, Volume: 14 Suppl 2 Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Radioimmunoassay; Recurrence; Schizophrenia	1991
Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients. The British journal of psychiatry : the journal of mental science, 1987, Volume: 151 Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Random Allocation; Schizophrenia	1987
A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence. Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:1 Suppl Topics: Administration, Oral; Adult; Chronic Disease; Clinical Trials as Topic; Female; Haloperidol; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Schizophrenia	1986
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia	1986

Other Studies

14 other study(ies) available for haloperidol decanoate and Chronic Disease

Article	Year
[Long-term therapy of chronic schizophrenic patients with haloperidol decanoate]. Psychiatrische Praxis, 1984, Volume: 11, Issue:2 Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Haloperidol; Humans; Long-Term Care; Male; Schizophrenia; Schizophrenic Psychology	1984
Pharmacokinetics of haloperidol decanoate. A 2-year follow-up. International pharmacopsychiatry, 1982, Volume: 17, Issue:4 Topics: Chronic Disease; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Kinetics; Male; Schizophrenia	1982
12-month study of haloperidol decanoate in chronic schizophrenic patients. International pharmacopsychiatry, 1982, Volume: 17, Issue:4 Topics: Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology	1982
Seasonal variation in the dexamethasone suppression test: a longitudinal study in chronic schizophrenics and in healthy subjects. Neuropsychobiology, 1994, Volume: 30, Issue:2-3 Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dexamethasone; Female; Haloperidol; Humans; Hydrocortisone; Longitudinal Studies; Male; Melatonin; Middle Aged; Psychiatric Status Rating Scales; Radioimmunoassay; Reference Values; Schizophrenia; Schizophrenic Psychology; Seasons	1994
A loading-dose strategy for converting from oral to depot haloperidol. Hospital & community psychiatry, 1993, Volume: 44, Issue:12 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Injections, Intramuscular; Longitudinal Studies; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Retrospective Studies; Schizophrenia; Schizophrenic Psychology	1993
Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients. Biological psychiatry, 1993, Apr-01, Volume: 33, Issue:7 Topics: Adult; Brain; Chronic Disease; Delayed-Action Preparations; Female; Haloperidol; Homovanillic Acid; Humans; Middle Aged; Schizophrenia; Schizophrenic Psychology	1993
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine. Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:1 Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia	1997
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Dec-15, Volume: 55, Issue:24 Suppl 4 Topics: Antipsychotic Agents; Baltimore; Chronic Disease; Delayed-Action Preparations; Disease-Free Survival; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Patient Readmission; Risperidone; Schizophrenia; Time Factors	1998
Outcome comparison of patients receiving oral or depot neuroleptic medication. Psychological reports, 2001, Volume: 89, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Cohort Studies; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia	2001
Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate. Clinical neuropharmacology, 1991, Volume: 14 Suppl 2 Topics: Antipsychotic Agents; Chronic Disease; Female; Follow-Up Studies; Haloperidol; Humans; Ireland; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology	1991
[Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients]. Acta psiquiatrica y psicologica de America latina, 1985, Volume: 31, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Drug Evaluation; Female; Haloperidol; Humans; Inpatients; Middle Aged; Psychotic Disorders	1985
Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics. Clinical neuropharmacology, 1986, Volume: 9 Suppl 4 Topics: Administration, Oral; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Delayed-Action Preparations; Haloperidol; Humans; Maintenance; Schizophrenia	1986
The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adult; Chronic Disease; Delayed-Action Preparations; Female; Haloperidol; Humans; Male; Schizophrenia	1986
Neuroendocrine effects of haloperidol decanoate in patients with chronic schizophrenia. Advances in biochemical psychopharmacology, 1985, Volume: 40 Topics: Adolescent; Adult; Chronic Disease; Drug Tolerance; Erectile Dysfunction; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia; Sex Factors; Sexual Dysfunction, Physiological; Time Factors	1985